Skip to main content

Table 1 Clinical data of IHS > 1.25 group and IHS ≤ 1.25 group

From: Risk factors analysis of attention deficit/hyperactivity disorder and allergic rhinitis in children: a cross-sectional study

variable

Total (n = 465)

IHS > 1.25 group (n = 122)

IHS ≤ 1.25 group (n = 343)

P

Age

9.53 ± 1.60

8.59 ± 1.41

9.79 ± 1.48

< 0.01

gender

219/246

68/54

151/192

< 0.01

Other allergic diseases (merged/not combined)

121/344

35/87

86/257

0.423

Allergens (simple/mixed)

302/163

74/48

228/115

0.221

Family history (with/without)

138/327

35/87

103/240

0.805

TNSS

SNAP-IV

5.68 ± 2.00

7.38 ± 1.69

5.04 ± 1.79

< 0.01

 Inattention

9.70 ± 5.40

15.48 ± 4.29

7.61 ± 4.01

< 0.01

 Hyperactivity/impulsivity

8.51 ± 5.03

13.91 ± 2.77

6.49 ± 3.13

< 0.01

IHS

1.01 ± 0.47

1.68 ± 0.29

0.78 ± 0.39

< 0.01

PRQLQ

 Nasal symptom score

2.46 ± 1.28

3.55 ± 1.09

2.04 ± 1.21

< 0.01

 Ocular symptoms score

1.79 ± 0.99

2.34 ± 0.96

1.67 ± 0.93

< 0.01

 Behavioral problem score

1.99 ± 0.88

2.61 ± 0.81

1.77 ± 0.84

< 0.01

Non-eye and nose symptoms score

1.34 ± 0.95

2.04 ± 0.83

1.09 ± 0.84

< 0.01

 Activity and sleep score

1.25 ± 0.77

1.74 ± 0.75

1.06 ± 0.73

< 0.01

AR duration in 1 year

  ≤ 1 month

142(30.5)

11 (8.6)

131 (38.1)

< 0.01

 1~3 months

139(29.9)

22 (18.1)

117 (34.1)

< 0.01

 3~6 months

112(24.1)

57 (46.6)

55 (16.1)

< 0.01

 6~9 months

49(10.5)

24 (19.8)

25 (7.4)

< 0.01

 9~12 months

23(4.9)

8 (6.9)

15 (4.3)

0.267

Skin index

 +

124(26.7)

17 (13.8)

107 (31.3)

< 0.01

 ++

182(39.1)

47 (38.8)

135 (39.3)

0.948

 +++

138(29.7)

48 (39.7)

90 (26.3)

< 0.01

 ++++

21(4.5)

10 (7.8)

11 (3.1)

0.031

  1. P:comparison between IHS > 1.25 group and IHS ≤ 1.25 group